Fortune May 9, 2025
The first-ever at-home screening test for cervical cancer earned approval by the Food and Drug Administration on Friday, paving the way for the DIY device to be in the hands of eligible women as early as next month. And it’s already in-network with big insurers Aetna, Cigna, and Blue Cross of California.
Developed by femtech startup Teal Health, the Teal Wand, which is modeled after a tampon, was shown in clinical trials to have the same accuracy as the cervical cancer test performed in your OB-GYN’s using a speculum. To date, the company has raised a total of $23 million with funding from Serena Ventures, Metrodora, and Labcorp.
While the at-home test won’t replace your visits to the gynecologist where...
Today's Sponsors
Today's Sponsor
Topics: Digital Health, Home, Interview / Q&A, Investments, Patient / Consumer, Physician, Provider, Technology, Trends